期刊文献+
共找到68篇文章
< 1 2 4 >
每页显示 20 50 100
Co-infection of Chlamydia psittaci and Tropheryma whipplei: A case report 被引量:1
1
作者 Zhu-Man Du Pei Chen 《World Journal of Clinical Cases》 SCIE 2023年第29期7144-7149,共6页
BACKGROUND The co-infection of Chlamydia psittaci(C.psittaci)and Tropheryma whipplei(T.whipplei)is unusual,and the detection of pathogenic microorganisms is particularly important for patients with severe diseases or ... BACKGROUND The co-infection of Chlamydia psittaci(C.psittaci)and Tropheryma whipplei(T.whipplei)is unusual,and the detection of pathogenic microorganisms is particularly important for patients with severe diseases or poor experience in treatment.Early identification of pathogens can significantly improve the prognosis of the patients.Targeted next-generation sequencing(tNGS)is currently widely used in clinical practice for various infectious diseases,including respiratory infections,to achieve early,accurate,and rapid microbial diagnosis.CASE SUMMARY We report a case of a 40-year-old female patient with a history of contact with parrots who was diagnosed with C.psittaci and T.whipplei infection through bronchial lavage fluid targeted next generation sequencing.After moxifloxacin treatment,the patient's symptoms improved significantly,and the imaging changes were obviously resolved.CONCLUSION Coinfection with C.psittaci and T.whipplei is not common.In this case,timely and accurate identification of both pathogens was achieved using tNGS.Moreover,the efficacy of monotherapy with moxifloxacin was confirmed. 展开更多
关键词 Infectious diseases Chlamydia psittaci Tropheryma whipplei targeted next generation sequencing Case report
下载PDF
Diagnostic, prognostic, and therapeutic implications of genetic profiling in pleural mesothelioma
2
作者 Ahmed Sadek Assunta De Rienzo Raphael Bueno 《Journal of Cancer Metastasis and Treatment》 CAS 2023年第1期131-147,共17页
Pleural mesothelioma(PM)is an aggressive malignancy of the pleural lining that typically arises secondary to asbestos exposure.With the advent of next-generation sequencing,major progress has been made in the molecula... Pleural mesothelioma(PM)is an aggressive malignancy of the pleural lining that typically arises secondary to asbestos exposure.With the advent of next-generation sequencing,major progress has been made in the molecular characterization of pleural mesothelioma over the past three decades.However,these advances have been largely unable to identify effective targeted therapies for PM.Additionally,there remains an absence of accepted gold-standard consensus for staging and treatment,which partly explains the overall poor outcomes in patients with PM.In recent years,genetic profiling of PM tumors has proved to be an effective tool in the diagnosis and prognosis of PM.Genomic sequencing has identified several potential targets for the development of novel therapeutics in PM.This review summarizes the progress in diagnosis,prognosis,and therapeutics derived by genomics and tumor profiling of PM tumors. 展开更多
关键词 Pleural mesothelioma gene-profiling next generation sequencing gene ratio profiling tumor biomarkers targeted therapies
原文传递
Targeting KRAS in pancreatic adenocarcinoma:Progress in demystifying the holy grail
3
作者 Ahmed Elhariri Ahmed Alhaj +10 位作者 Daniel Ahn Mohamad Bassam Sonbol Tanios Bekaii-Saab Christina Wu Michael Scott Rutenberg John Stauffer Jason Starr Umair Majeed Jeremy Jones Mitesh Borad Hani Babiker 《World Journal of Clinical Oncology》 2023年第8期285-296,共12页
Pancreatic cancer(PC)remains one of the most challenging diseases,with a very poor 5-year overall survival of around 11.5%.Kirsten rat sarcoma virus(KRAS)mutation is seen in 90%-95%of PC patients and plays an importan... Pancreatic cancer(PC)remains one of the most challenging diseases,with a very poor 5-year overall survival of around 11.5%.Kirsten rat sarcoma virus(KRAS)mutation is seen in 90%-95%of PC patients and plays an important role in cancer cell proliferation,differentiation,metabolism,and survival,making it an essential mutation for targeted therapy.Despite extensive efforts in studying this oncogene,there has been little success in finding a drug to target this pathway,labelling it for decades as“undruggable”.In this article we summarize some of the efforts made to target the KRAS pathway in PC,discuss the challenges,and shed light on promising clinical trials. 展开更多
关键词 Kirsten rat sarcoma virus targeted therapy Pancreatic cancer Drug resistance next generation sequencing Clustered regularly interspaced short palindromic repeats
下载PDF
基于多重长PCR靶向捕获测序技术的高同源SNP鉴定 被引量:1
4
作者 王决恒 周宇荀 +1 位作者 李凯 肖君华 《东华大学学报(自然科学版)》 CAS 北大核心 2024年第1期163-170,共8页
为建立一种高同源区段的单核苷酸多态性(SNP)基因分型技术,通过构建本地Blast对SNP所在的200和400 bp区段进行同源性评估,并筛选出高同源区段的SNP。利用第一轮多重长PCR(polymerase chain reaction)捕获329个样本的9个高同源区段SNP所... 为建立一种高同源区段的单核苷酸多态性(SNP)基因分型技术,通过构建本地Blast对SNP所在的200和400 bp区段进行同源性评估,并筛选出高同源区段的SNP。利用第一轮多重长PCR(polymerase chain reaction)捕获329个样本的9个高同源区段SNP所在的长片段,使用纯化后的第一轮PCR产物作为模板进行扩增子建库测序,检测样本共得2 928个SNP位点信息,测序成功率高达98.885 6%。利用Hardy-Weinberg(HWE)法则计算试验研究的9个高同源区段SNP位点的基因频率(p值均大于0.05,符合HWE法则),并与NCBI(national center for biotechnology information)中千人基因组数据库中获取的基因频率相比对,发现二者单碱基基因频率一致(误差限<0.15)。研究表明,利用多重长PCR靶向捕获技术结合二代测序技术为高同源区段的SNP分型提供一个准确、快速、大样本检测方案。 展开更多
关键词 SNP分型 高同源区段 多重长PCR靶向捕获技术 高通量测序
下载PDF
Plant phylogenomics based on genome-partitioning strategies:Progress and prospects 被引量:7
5
作者 Xiangqin Yu Dan Yang +1 位作者 Cen Guo Lianming Gao 《Plant Diversity》 SCIE CAS CSCD 2018年第4期158-164,共7页
The rapid expansion of next-generation sequencing (NGS) has generated a powerful array of approaches to address fundamental questions in biology. Several genome-partitioning strategies to sequence selected subsets o... The rapid expansion of next-generation sequencing (NGS) has generated a powerful array of approaches to address fundamental questions in biology. Several genome-partitioning strategies to sequence selected subsets of the genome have emerged in the fields of phylogenomics and evolutionary genomics. In this review, we summarize the applications, advantages and limitations of four NGS-based genome- partitioning approaches in plant phylogenomics: genome skimming, transcriptome sequencing (RNA- seq), restriction site associated DNA sequencing (RAD-Seq), and targeted capture (Hyb-seq). Of these four genome-partitioning approaches, targeted capture (especially Hyb-seq) shows the greatest promise for plant phy^ogenetics over the next fex~ years. This reviex~ wi~ aid ~esea^chers in their selection of appropriate genome-partitioning approaches to address questions of evolutionary scale, where we anticipate continued development and expansion ofwhole-genome sequencing strategies in the fields of plant phylogenomics and evolutionary biology research. 展开更多
关键词 Plant phylogenomics next-generation sequencing Whole-genome sequencing Genome skimming RAD-Seq targeted capture
下载PDF
Cultural Isolation and Characteristics of the Blood Microbiome of Healthy Individuals 被引量:3
6
作者 Stefan Panaiotov Georgi Filevski +2 位作者 Michele Equestre Elena Nikolova Reni Kalfin 《Advances in Microbiology》 2018年第5期406-421,共16页
Background: On the analogy of the non-pathogenic microbiota found in oral cavity, skin and gastrointestinal tract, existence of blood microbiota was confirmed by DNA sequencing, but never deeply characterized. Hypothe... Background: On the analogy of the non-pathogenic microbiota found in oral cavity, skin and gastrointestinal tract, existence of blood microbiota was confirmed by DNA sequencing, but never deeply characterized. Hypothesis for the existence of dormant blood microbiota in healthy humans have been arisen and single species have been isolated. The aim of our study was to resuscitate and investigate the biodiversity of bacterial and fungal dormant blood microbiota in healthy individuals by blood culturing and NGS DNA sequencing. Results: Twenty eight blood samples of healthy individuals, seven for each blood type, were studied. Several culture media were tested. Blood microbiota resuscitation was performed in BHI broth supplemented with vitamin K 1 mg/ml, 2% sucrose, 0.25% sodium citrate and 0.2% yeastolate at 43?C for 72 h. All tested blood samples were culture positive, as confirmed by Gram staining and TEM. TEM images demonstrated well defined cell structures. Analysis for bacterial and eukaryotic species was performed by 16S rRNA and ITS2 targeted sequencing. The obtained sequences were clustered (≥97% identity) in Operational Taxonomic Units (OTUs). Among cultured and uncultured samples we identified OTUs similarity with 47 bacterial orders belonging to 15 phyla and 39 fungi orders blonging to 2 phyla. For the first time we demonstrated isolation and sequencing identification of fungal blood microbiota in healthy individuals. Blood-group differences were identified among the bacterial microbiome compositions. Conclusion: The dormant blood microbiome is innate of the healthy individuals. Interventional strategies to bind the host blood microbiome with the states of health and disease remain an unmet research goal. 展开更多
关键词 BLOOD MICROBIOTA targetED next generation sequencing Operational TAXONOMIC Unit
下载PDF
VSITA, an Improved Approach of Target Amplification in the Identification of Viral Pathogens 被引量:3
7
作者 ZHANG Yi ZHANG Chen +11 位作者 LI Bo LI Yang HE Xiao Zhou LI Acher WU Wei DUAN Su Xia QIU Fang Zhou WANG Ji SHEN Xin Xin YANG Meng Jie LI De Xin MA Xue Jun 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2018年第4期272-279,共8页
Objective Unbiased next generation sequencing(NGS) is susceptible to interference from host or environmental sequences. Consequently, background depletion and virome enrichment techniques are usually needed for clin... Objective Unbiased next generation sequencing(NGS) is susceptible to interference from host or environmental sequences. Consequently, background depletion and virome enrichment techniques are usually needed for clinical samples where viral load is much lower than background sequences. Methods A viral Sequence Independent Targeted Amplification(VSITA) approach using a set of non-ribosomal and virus-enriched octamers(V8) was developed and compared with traditionally used random hexamers(N6). Forty-five archived clinical samples of different types were used in parallel to compare the V8 and N6 enrichment performance of viral sequences and removal performance of ribosomal sequences in the step of reverse transcription followed by quantitative PCR(qP CR). Ten sera samples from patients with fever of unknown origin and 10 feces samples from patients with diarrhea of unknown origin were used in comparison of V8 and N6 enrichment performance following NGS analysis. Results A minimum 30 hexamers matching to viral reference sequences(sense and antisense) were selected from a dataset of random 4,096(4~6) hexamers(N6). Two random nucleotides were added to the 5' end of the selected hexamers, and 480(30 × 4~2) octamers(V8) were obtained. In general, VSITA approach showed higher enrichment of virus-targeted c DNA and enhanced ability to remove unwanted ribosomal sequences in the majorities of 45 predefined clinical samples. Moreover, VSITA combined with NGS enabled to detect not only more viruses but also achieve more viral reads hit and higher viral genome coverage in 20 clinical samples with diarrhea or fever of unknown origin. Conclusion The VSITA approach designed in this study is demonstrated to possess higher sensitivity and broader genome coverage than traditionally used random hexamers in the NGS-based identification of viral pathogens directly from clinical samples. 展开更多
关键词 Virus next generation sequencing Non-ribosomal Virus targeted
下载PDF
基于捕获法的靶向测序技术在弥漫大B细胞淋巴瘤IgH基因重排检测中的应用价值 被引量:1
8
作者 李三恩 石晨曦 +2 位作者 朱卫东 王玉红 郭凌川 《临床与实验病理学杂志》 CAS 北大核心 2023年第3期317-320,共4页
目的探讨基于捕获法的靶向测序技术在弥漫大B细胞淋巴瘤IgH基因克隆性重排检测中的应用价值。方法收集2020年3月~2022年1月苏州大学附属第一医院送检的DLBCL标本99例,提取患者基因组DNA,使用基于捕获法的靶向测序技术进行IgH基因克隆性... 目的探讨基于捕获法的靶向测序技术在弥漫大B细胞淋巴瘤IgH基因克隆性重排检测中的应用价值。方法收集2020年3月~2022年1月苏州大学附属第一医院送检的DLBCL标本99例,提取患者基因组DNA,使用基于捕获法的靶向测序技术进行IgH基因克隆性重排检测。结果27.3%(27/99)患者检测到IgH基因完全IgHV-IgHD-IgHJ重排,50.5%(50/99)患者检测到IgH基因不完全IgHD-IgHJ重排,IgH基因克隆性重排联合检出率为66.7%(66/99)。27例患者检测到32种IgHV-IgHD-IgHJ重排,50例患者检测到52种IgHD-IgHJ重排,在IgHV-IgHD-IgHJ重排中,IgHV3、IgHD3和IgHJ4家族基因的取用频率最高,在IgHD-IgHJ重排中,IgHD3和IgHJ4家族基因的取用频率最高。3例患者捕获到未知IgH基因融合伴侣,其中2例为MIR4507-IgH融合,1例为IRF8-IgH融合。结论基于捕获法的靶向测序技术不仅可以检测IgH基因克隆性重排具体方式,还能发现IgH基因未知融合伴侣,对DLBCL诊断及个体化治疗策略制定具有重要意义。 展开更多
关键词 淋巴瘤 弥漫大B细胞淋巴瘤 捕获法 靶向测序 IGH基因重排
下载PDF
Development of high-resolution multiple-SNP arrays for genetic analyses and molecular breeding through genotyping by target sequencing and liquid chip 被引量:10
9
作者 Zifeng Guo Quannv Yang +11 位作者 Feifei Huang Hongjian Zheng Zhiqin Sang Yanfen Xu Cong Zhang Kunsheng Wu Jiajun Tao Boddupalli MPrasanna Michael SOlsen Yunbo Wang Jianan Zhang Yunbi Xu 《Plant Communications》 SCIE 2021年第6期12-26,共15页
Genotyping platforms,as critical supports for genomics,genetics,and molecular breeding,have been well implemented at national institutions/universities in developed countries and multinational seed companies that poss... Genotyping platforms,as critical supports for genomics,genetics,and molecular breeding,have been well implemented at national institutions/universities in developed countries and multinational seed companies that possess high-throughput,automatic,large-scale,and shared facilities.In this study,we integrated an improved genotyping by target sequencing(GBTS)system with capture-in-solution(liquid chip)technology to develop a multiple single-nucleotide polymorphism(mSNP)approach in which mSNPs can be captured from a single amplicon.From one 40K maize mSNP panel,we developed three types of markers(40K mSNPs,251K SNPs,and 690K haplotypes),and generated multiple panels with various marker densities(1K–40K mSNPs)by sequencing at different depths.Comparative genetic diversity analysis was performed with genic versus intergenic markers and di-allelic SNPs versus non-typical SNPs.Compared with the one-amplicon-one-SNP system,mSNPs and within-mSNP haplotypes are more powerful for genetic diversity detection,linkage disequilibrium decay analysis,and genome-wide association studies.The technologies,protocols,and application scenarios developed for maize in this study will serve as a model for the development of mSNP arrays and highly efficient GBTS systems in animals,plants,and microorganisms. 展开更多
关键词 multiple single-nucleotide polymorphisms mSNPs genotyping by target sequencing GBTS multiplexing PCR sequence capture in-solution(liquid chip) linkage disequilibrium LD
原文传递
Novel applications of next-generation sequencing in breast cancer research
10
作者 Rong Ma Jianping Gong Xiaowei Jiang 《Genes & Diseases》 SCIE 2017年第3期149-153,共5页
With the rapid development of medicine,the studies of genes have become increasingly concerned by more people and being the contend of a great of researches.The next generation sequencing with its own advantages has b... With the rapid development of medicine,the studies of genes have become increasingly concerned by more people and being the contend of a great of researches.The next generation sequencing with its own advantages has been widely used in gene research nowadays.It has almost replaced the traditional sequencing methods(such as Sanger sequencing method),and played an important role in a variety of complex disease researches,including breast cancer.The next generation sequencing technology has the advantages of high speed,high throughput and high accuracy.It has been widely used in various cancers(such as prostate cancer,lung cancer,pancreatic cancer,liver cancer,etc.),especially in breast cancer.Moreover,the use of the next generation sequencing technology to make DNA sequence analysis and risk prediction has made a great contribution to the research of breast cancer.We will focus on the application of whole genome sequencing,exon sequencing and targeted gene sequencing in breast cancer gene research. 展开更多
关键词 Breast cancer The next generation sequencing technology The targeted sequencing The whole genome association studies The whole genome exon sequencing
原文传递
目标序列捕获及平行测序在临床耳聋基因诊断中的应用 被引量:12
11
作者 苏钰 汤文学 +6 位作者 代志瑶 高雪 王国建 黄莎莎 康东洋 林曦 戴朴 《中华耳科学杂志》 CSCD 北大核心 2014年第1期45-49,共5页
目的利用目标序列捕获(Targeted sequence capture)、生物编码(Barcode)及大规模平行测序(Massivelyparallel sequencing,MPS)技术,对遗传性耳聋患者进行分子病因学研究,探索低成本、多基因、多样本的耳聋基因检测在临床应用的可行性。... 目的利用目标序列捕获(Targeted sequence capture)、生物编码(Barcode)及大规模平行测序(Massivelyparallel sequencing,MPS)技术,对遗传性耳聋患者进行分子病因学研究,探索低成本、多基因、多样本的耳聋基因检测在临床应用的可行性。方法利用Illumina测序平台对来自解放军总医院聋病分子诊断中心88例(来自61个家系)具有明确家族史且常见耳聋基因检测阴性的耳聋患者,以及8例阳性对照患者进行42种基因的目标序列捕获、Barcode和MPS,并对测序结果进行生物信息学分析。结果利用上述方法在88个个体中大于一人入组家系中发现了10个家系8个基因(TECTA、DFNA5、CDH23、USH1C、MYO7A、POU3F4、SLC26A4、EYA4)14个位点的致病性突变。准确验证了8个阳性对照。大于一人入组家系的致病基因检出率明显高于单人入组家系。结论高通量测序的发展为遗传性耳聋的诊断带来了巨大的机遇。目标序列捕获、Barcode、MPS的结合进一步提高了测序的准确性、降低了测序成本,同时生物信息学的进步,将促进低成本、多基因、多样本的临床耳聋基因检测成为可能。 展开更多
关键词 遗传性耳聋 目标序列捕获 生物编码 平行测序 生物信息学
下载PDF
目标序列捕获测序检出红细胞丙酮酸激酶缺乏症PKLR基因新的复合突变 被引量:4
12
作者 李栋梁 张静 +8 位作者 刘艳丽 焦保全 王志伟 王友君 李文静 侯兰芬 郭宏谋 孙宇 郭晓 《中国实验血液学杂志》 CAS CSCD 北大核心 2015年第5期1464-1468,共5页
目的:探讨红细胞丙酮酸激酶缺乏症(pyruvate kinase deficiency,PKD)的分子发病机制。方法:应用目标序列捕获和高通量二代测序技术(next-generation sequencing,NGS)对临床拟诊PKD患儿的PKLR基因12个外显子及其侧翼序列进行测序,采用SIF... 目的:探讨红细胞丙酮酸激酶缺乏症(pyruvate kinase deficiency,PKD)的分子发病机制。方法:应用目标序列捕获和高通量二代测序技术(next-generation sequencing,NGS)对临床拟诊PKD患儿的PKLR基因12个外显子及其侧翼序列进行测序,采用SIFT及PolyPhen-2数据库预测突变对蛋白质功能的影响,在确定患者致病基因型后,应用Sanger测序技术对此基因型进行验证。结果:NGS结果显示,患儿PKLR基因存在罕见的双重杂合突变:第5外显子661G>A(Asp221Asn)和第10外显子1528C>T(Arg510Ter),导致该基因的第221位氨基酸由天冬氨酸突变为天冬酰胺,第510位氨基酸由精氨酸突变为终止密码子,使PKLR基因氨基酸链编码提前终止;Sanger测序技术进一步验证了该双重突变的存在。检索相关文献及数据库显示,这两种突变在人群中的发生率极低,蛋白质功能预测均显示为有害。结论:PKLR基因661 G>A与1528 C>T双重杂合突变是该PKD患儿的分子发病机制,PKD患者同时存在上述复合突变的报道在国内外尚属首次。 展开更多
关键词 基因 突变 丙酮酸激酶 目标序列捕获 二代测序
下载PDF
靶向测序基因型检测(GBTS)技术及其应用 被引量:57
13
作者 徐云碧 杨泉女 +10 位作者 郑洪建 许彦芬 桑志勤 郭子锋 彭海 张丛 蓝昊发 王蕴波 吴坤生 陶家军 张嘉楠 《中国农业科学》 CAS CSCD 北大核心 2020年第15期2983-3004,共22页
借助于分子标记进行基因型检测的技术在生物遗传改良等领域发挥着重要的作用。国际跨国种业公司凭借其高通量、自动化、大规模的共享检测平台,基因型检测技术得到广泛应用。随着从3G时代的高成本固相芯片和随机测序式基因型检测(genotyp... 借助于分子标记进行基因型检测的技术在生物遗传改良等领域发挥着重要的作用。国际跨国种业公司凭借其高通量、自动化、大规模的共享检测平台,基因型检测技术得到广泛应用。随着从3G时代的高成本固相芯片和随机测序式基因型检测(genotyping by sequencing,GBS)发展到成本低、对检测平台要求较低、基于靶向测序基因型检测(genotyping by target sequencing,GBTS)的液相芯片,基因型检测技术完成了向4G时代的转变。在本文中首先介绍了两项最新的GBTS技术(基于多重PCR的GenoPlexs和基于液相探针捕获的GenoBaits)及其原理。同时,发展了可以在单个扩增子内检测多个SNP,称之为多聚单核苷酸多态性(multiple single-nucleotide-polymorphism cluster,mSNP或multiple dispersed nucleotide polymorphism,MNP)的技术,极大地提高了目标位点(扩增子)内变异的检测效率。与GBS和固相芯片相比,GBTS技术具有平台广适性、标记灵活性、检测高效性、信息可加性、支撑便捷性和应用广谱性。同一款标记集(例如玉米40K mSNP),可以获得3种不同的标记形式(40K mSNP、260K SNP和754K单倍型);并可以根据应用场景的需求,通过控制测序深度获得多种不同的标记密度(1-40K mSNP)。GenoPlexs和GenoBaits 2种技术相结合,可广泛应用于生物进化、遗传图谱构建、基因定位克隆、标记性状关联检测(全基因组关联分析——GWAS和混合样本分析——BSA)、后裔鉴定、基因渐渗、基因累加、品种权保护、品种质量监测、转基因成分/基因编辑/伴生生物检测等领域。目前,已经在20余种主要农作物、蔬菜以及部分动物和微生物中开发了GBTS标记50余套,并已广泛应用于上述领域。最后,展望了与未来GBTS应用相关的几个问题,包括便携式、自动化、高通量、智能化检测平台;根据用户需求定制的可变密度、多功能分子检测;GBTS与其他技术(KASP、高密度芯片、BSA策略等)的整合;基于资源共享的开源育种等。这些将推动GBTS技术在动物、植物和微生物遗传改良等领域的广泛应用。 展开更多
关键词 靶向测序基因型检测(GBTS) 多重PCR 液相探针 多聚单核苷酸多态性(mSNP) 多个分散型核苷酸多态性(MNP) 单倍型 遗传改良 开源育种
下载PDF
目标基因捕获测序技术检测1例肥厚型心肌病致病基因突变 被引量:4
14
作者 刘旭霞 姜腾勇 +3 位作者 郭俊 郑帅 王绿娅 杜杰 《临床检验杂志》 CAS CSCD 北大核心 2014年第5期333-336,共4页
目的通过靶向捕获高通量测序技术初步筛查肥厚型心肌病(HCM)致病基因突变。方法收集1例HCM患者临床信息和外周血,并提取基因组DNA,制备DNA全基因组文库。挑选导致HCM的8个候选基因,用GenCap基因序列捕获技术靶向富集该患者外周血DNA候... 目的通过靶向捕获高通量测序技术初步筛查肥厚型心肌病(HCM)致病基因突变。方法收集1例HCM患者临床信息和外周血,并提取基因组DNA,制备DNA全基因组文库。挑选导致HCM的8个候选基因,用GenCap基因序列捕获技术靶向富集该患者外周血DNA候选基因并行高通量测序。通过生物信息学分析筛选致病突变。用Sanger测序来验证相应致病基因突变位点。结果目标基因靶向捕获测序结果经与公共数据库和内部健康人测序数据库对比,发现致病基因突变位点MYBPC3 D770N,该致病基因突变与Sanger测序结果一致。结论用目标基因靶向捕获测序技术可实现对HCM致病基因突变的初步筛查,对HCM的临床基因诊断具有潜在的应用价值。 展开更多
关键词 肥厚型心肌病 突变 靶向捕获 高通量测序
下载PDF
利用目标基因测序技术发现马方综合征FBN1新突变 被引量:8
15
作者 郭俊 蔡伦 +2 位作者 李小燕 王绿娅 杜杰 《心肺血管病杂志》 CAS 2014年第4期596-598,603,共4页
目的:建立目标基因捕获结合第二代测序技术,对马方综合征(Marfan syndrome,MFS)患者的原纤维蛋白-1(fibrillin-1,FBN1)基因进行突变筛查,探讨MFS与FBN1基因突变的关系.方法:提取5例MFS患者外周血全基因组DNA,利用GenCap目标基因... 目的:建立目标基因捕获结合第二代测序技术,对马方综合征(Marfan syndrome,MFS)患者的原纤维蛋白-1(fibrillin-1,FBN1)基因进行突变筛查,探讨MFS与FBN1基因突变的关系.方法:提取5例MFS患者外周血全基因组DNA,利用GenCap目标基因捕获技术(北京迈基诺公司),设计FBN1的65个外显子区域特异性捕获探针,与基因组DNA文库进行杂交,将目标基因组区域的DNA片段进行富集后,再利用illumina hiseq2000第二代测序仪进行测序,通过数据分析,确定突变位点,用Sanger测序法对突变位点进行验证.结果:设计合成的目标基因特异性捕获探针可有效地捕捉并富集基因组DNA的目标靶片段.5例患者目标区域平均测序深度为173.85 ~ 280.73,97.10% ~ 98.00%目标区域>4×覆盖度.经过数据分析及Sanger测序验证,发现1个新的无义突变c.5968 C>T(p.Gln1990X).结论:本研究所建立的GenCap目标基因捕获技术结合illumina hiseq2000第二代测序技术成功的发现了FBN1的新突变.该方法快速而有效,可以使我们对MFS分子病因学有更好的认识. 展开更多
关键词 马方综合征 原纤维蛋白-1 目标基因捕获 第二代测序
下载PDF
目标序列捕获二代测序技术在苯丙酮尿症基因诊断中的应用 被引量:3
16
作者 陈瑛 魏晓明 +2 位作者 王本敬 易鑫 毛君 《复旦学报(医学版)》 CAS CSCD 北大核心 2015年第3期403-408,共6页
目的评估目标序列捕获二代测序技术在苯丙酮尿症(phenylketonuria,PKU)基因诊断中的应用价值。方法采用目标区序列捕获及第二代测序技术对9例经典型PKU患者的苯丙氨酸羟化酶(phenylalanine hydroxylase,PAH)基因进行检测;采用Sanger测... 目的评估目标序列捕获二代测序技术在苯丙酮尿症(phenylketonuria,PKU)基因诊断中的应用价值。方法采用目标区序列捕获及第二代测序技术对9例经典型PKU患者的苯丙氨酸羟化酶(phenylalanine hydroxylase,PAH)基因进行检测;采用Sanger测序技术对患者及其父母基因突变型进行验证。结果 9例患者检测到PAH基因的12种致病性突变,包括7种错义突变(p.I65T、p.F161S、p.Q204C、p.R241C、p.L242F、p.R243Q和p.Q375E),2种无义突变(p.R111X和p.Y356X),3种剪接突变[c.442-1G>A(IVS4-1G>A)、c.1315+6T>A(IVS12+6T>A)和c.1316-2A>C(IVS12-2A>C)],以及3种非致病性的变异(p.Q232Q、p.V245V和p.L385L),致病性突变均来自患者父母。其中,2个致病性突变未见报道,分别为c.1316-2A>C和p.Q375E(CAA->GAA)。结论目标序列捕获二代测序可以准确检测出PAH基因突变,对遗传病因明确的疾病具有一定的临床应用价值。 展开更多
关键词 苯丙酮尿症 苯丙氨酸羟化酶 序列捕获 第二代测序技术
下载PDF
目标基因捕获测序技术鉴定肥厚型心肌病致病突变的研究 被引量:5
17
作者 刘旭霞 姜腾勇 +3 位作者 朴春梅 李小燕 王绿娅 杜杰 《心肺血管病杂志》 CAS 2014年第4期599-603,共5页
目的:利用目标基因靶向捕获高通量测序方法鉴定肥厚型心肌病(hypertrophic cardiomyopathy,HCM)致病突变,并进行基因型-临床表型的分析,以期对临床诊治提供参考依据。方法:连续收集10例HCM患者血液与临床资料。提取全血基因组DNA、文库... 目的:利用目标基因靶向捕获高通量测序方法鉴定肥厚型心肌病(hypertrophic cardiomyopathy,HCM)致病突变,并进行基因型-临床表型的分析,以期对临床诊治提供参考依据。方法:连续收集10例HCM患者血液与临床资料。提取全血基因组DNA、文库制备,靶向富集8个编码肌小节蛋白的HCM的致病基因,并行高通量测序。结果:10例患者[平均年龄为(46±7.9)岁,女性占50%]中,4例患者发现5个基因突变位点。双突变(TNNT2 R286H和MYH7 R663H)携带者具有HCM家族史,发病早,左心室重度肥厚,心电图呈现传导阻滞。MYBPC3 D770N和MYBPC3 S236G突变携带者发病年龄晚,左心室肥厚程度较轻。MYH7 R869C突变携带者年龄大,左心室肥厚程度较重,心电图呈现明显左心室肥大证据。结论:对10例HCM患者利用目标基因捕获测序技术筛选出5个致病突变。携带不同突变的患者其临床表型不一致,这对患者的预后和治疗提供了有利的依据。 展开更多
关键词 肥厚型心肌病 突变 目标捕获 高通量测序
下载PDF
利用目标基因捕获结合二代测序技术发现左心室心肌致密化不全MYBPC3基因错义突变 被引量:6
18
作者 李然 郭俊 +4 位作者 丁文虹 焦萌 李小燕 王绿娅 杜杰 《心肺血管病杂志》 2016年第1期20-24,共5页
目的:建立目标基因捕获结合第二代测序技术,对孤立性左心室心肌致密化不全(IVNC)患者的已知致病基因MYBPC3进行突变筛查。方法:收集5例IVNC患者及一级亲属的超声影像学资料,并提取外周血全基因组DNA,设计MYBPC3外显子区域特异性捕获探针... 目的:建立目标基因捕获结合第二代测序技术,对孤立性左心室心肌致密化不全(IVNC)患者的已知致病基因MYBPC3进行突变筛查。方法:收集5例IVNC患者及一级亲属的超声影像学资料,并提取外周血全基因组DNA,设计MYBPC3外显子区域特异性捕获探针,与基因组DNA文库进行杂交,富集目标基因组区域DNA片段,利用二代测序技术,确定突变位点,并使用Sanger测序法在其一代亲属中验证。结果:目标基因特异性捕获探针可有效地捕捉并富集基因组DNA目标靶片段。在5例IVNC患者中,发现1例MYBPC3基因杂合非同义突变c.G1000A(p.E334K),该突变位于MYBPC3基因第13外显子中,测序深度249.65。经过数据分析与Sanger测序验证后,父亲发现此突变位点,母亲未发现提示突变的父亲的遗传。结论:本研究所建立的Gen Cap目标基因捕获测序技术结合二代测序技术成功发现了MYBPC3基因突变。 展开更多
关键词 孤立性左心室心肌致密化不全 MYBPC3基因 目标基因捕获技术 二代测序技术
下载PDF
外显子目标区域捕获技术在胎儿骨骼畸形产前诊断中的应用——附30例临床病例分析 被引量:4
19
作者 刘妍 吴青青 +4 位作者 杨怡珂 梁颖 张铁娟 梁娜 杨丽曼 《医学综述》 2018年第16期3279-3288,共10页
目的探讨胎儿骨骼发育异常的基因诊断,为胎儿骨骼畸形的产前诊断分析及遗传咨询指导提供相应理论依据。方法选择2014年1月至2017年6月在首都医科大学附属北京妇产医院超声提示胎儿骨骼发育异常的30例病例为研究对象,其中15例胎儿局部骨... 目的探讨胎儿骨骼发育异常的基因诊断,为胎儿骨骼畸形的产前诊断分析及遗传咨询指导提供相应理论依据。方法选择2014年1月至2017年6月在首都医科大学附属北京妇产医院超声提示胎儿骨骼发育异常的30例病例为研究对象,其中15例胎儿局部骨骼畸形,15例胎儿短肢畸形。所有病例均留取胎儿脐血、羊水或流产组织,按技术路线依次进行胎儿染色体、全基因组测序及363个骨骼相关致病基因全外显子检测,并同时留取父母血样进行Sanger验证。结果 30例骨骼发育不良病例中,2例18-三体,余28例染色体正常的胎儿均未发现与骨骼发育异常相关的微缺失/微重复变异,21例均携带骨病相关基因。6例短肢畸形患者检测出胶原类基因突变,7例检测出携带成纤维细胞生长因子受体3基因的杂合已知致病突变,其余分别携带TP63、EBP、CHRNG、FLNB、SOX9等基因。其中3例复合杂合突变(CHRNG、COL11A2、SOX9)分别来源于表型健康的夫妻双方。结论目标区域外显子捕获技术能显著提高胎儿骨骼发育异常的产前诊断阳性率,为患者提供更全面的产前诊断分析、遗传咨询指导、手术及药物靶向治疗。 展开更多
关键词 胎儿骨骼发育异常 染色体 全基因组测序 全外显子检测 产前诊断 遗传咨询
下载PDF
目标基因捕获测序技术检测肺动脉高压致病基因突变的研究 被引量:2
20
作者 朴春梅 朱燕 +3 位作者 习昕 张陈 杜杰 顾虹 《心肺血管病杂志》 CAS 2015年第3期228-231,共4页
目的:利用目标基因捕获测序技术,对9例肺动脉高压(PAH)患者进行4个已知致病基因突变筛查,探讨利用目标基因捕获测序技术对PAH进行基因诊断的可行性。方法:抽取PAH患者外周血,提取全基因组DNA,制备文库。设计骨形成蛋白2型受体(BMPR2)、... 目的:利用目标基因捕获测序技术,对9例肺动脉高压(PAH)患者进行4个已知致病基因突变筛查,探讨利用目标基因捕获测序技术对PAH进行基因诊断的可行性。方法:抽取PAH患者外周血,提取全基因组DNA,制备文库。设计骨形成蛋白2型受体(BMPR2)、激活素受体样激酶1(ACVR1)、细胞内皮糖蛋白(En G),信号蛋白SMAD4基因(SMAD4)外显子区域特异性捕获探计,利用目标基因捕获技术,进行杂交,富集目标基因组区域的DNA片段,利用Illumina Hi Seq 2000进行高通量测序,分析致病基因突变与PAH的相关性。结果:9例患者中,2例患者发现BMPR2基因突变,1例发现ACVRL1突变,BMPR2突变临床症状较重,ACVRL1突变发病年龄较小。结论:本研究利用目标基因捕获测序技术,在9例PAH患者中查出3个致病基因突变。该方法快速有效,可实现对PAH致病基因突变的初步筛查,对PAH的临床基因诊断具有重要价值。 展开更多
关键词 肺动脉高压 目标基因捕获 高通量测序 突变
下载PDF
上一页 1 2 4 下一页 到第
使用帮助 返回顶部